Fluid biomarkers in Alzheimer’s disease – current concepts

Fluid biomarkers in Alzheimer’s disease – current concepts

The diagnostic guidelines of Alzheimer’s disease (AD) have recently been updated to include brain imaging and cerebrospinal fluid (CSF) biomarkers, with the aim of increasing the certainty of whether a patient has an ongoing AD neuropathologic process or not. The CSF biomarkers total tau (T-tau), hy...

Full description

Bibliographic Details
Main Authors:	Rosén, Christoffer, Hansson, Oskar, Blennow, Kaj, Zetterberg, Henrik
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691925/

Similar Items

Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study
by: Stomrud, Erik, et al.
Published: (2015)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
by: Janelidze, Shorena, et al.
Published: (2015)

Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
by: Hölttä, Mikko, et al.
Published: (2013)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
by: Hall, Sara, et al.
Published: (2016)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
by: Mattsson, Niklas, et al.
Published: (2016)

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
by: Palmqvist, Sebastian, et al.
Published: (2015)

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
by: Blennow, Kaj, et al.
Published: (2015)

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
by: Skillbäck, Tobias, et al.
Published: (2013)

Plasma tau levels in Alzheimer's disease
by: Zetterberg, Henrik, et al.
Published: (2013)

Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study
by: Palmqvist, Sebastian, et al.
Published: (2012)

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease
by: Rosén, Christoffer, et al.
Published: (2014)

Biomarkers for Microglial Activation in Alzheimer's Disease
by: Lautner, Ronald, et al.
Published: (2011)

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
by: Brinkmalm, Ann, et al.
Published: (2014)

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates
by: Mulugeta, Ezra, et al.
Published: (2011)

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
by: Öhrfelt, Annika, et al.
Published: (2016)

No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
by: Cicognola, Claudia, et al.
Published: (2016)

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
by: Hansson, Oskar, et al.
Published: (2014)

Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease
by: Johansson, Per, et al.
Published: (2013)

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.
by: Per Johansson, et al.

Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease
by: Voevodskaya, Olga, et al.
Published: (2016)

Plasma β-amyloid in Alzheimer’s disease and vascular disease
by: Janelidze, Shorena, et al.
Published: (2016)

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease
by: Öhrfelt, Annika, et al.
Published: (2016)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
by: Andreasson, Ulf, et al.
Published: (2016)

APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment
by: Sjödin, Simon, et al.
Published: (2015)

Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases
by: Rosén, Christoffer, et al.
Published: (2011)

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
by: Sarah Westwood, et al.
Published: (2017-04-01)

A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer’s Disease
by: Andersson, Carl-Henrik, et al.
Published: (2016)

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
by: Heslegrave, Amanda, et al.
Published: (2016)

The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer’s disease
by: Mäkitalo, Signar, et al.
Published: (2015)

Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer’s Disease
by: Armstrong, Andrea, et al.
Published: (2013)

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer's Disease
by: Öhrfelt, Annika, et al.
Published: (2011)

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
by: Piotr Lewczuk, et al.
Published: (2018-07-01)

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
by: Kvartsberg, Hlin, et al.
Published: (2015)

Plasma tau in Alzheimer disease
by: Mattsson, Niklas, et al.
Published: (2016)

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
by: Forlenza, Orestes V., et al.
Published: (2015)

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
by: Rosengren Lars, et al.
Published: (2010-07-01)

Levels of ADAM10 are reduced in Alzheimer’s disease CSF
by: Aitana Sogorb-Esteve, et al.
Published: (2018-07-01)

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
by: Janelidze, Shorena, et al.
Published: (2016)

Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy Controls
by: Rolstad, Sindre, et al.
Published: (2015)

Peptidome Analysis of Cerebrospinal Fluid by LC-MALDI MS
by: Hölttä, Mikko, et al.
Published: (2012)